The effectiveness of bone density measurement and associated treatments for prevention of fractures: An international collaborative review

International Journal of Technology Assessment in Health Care

Volumn 14, Issue 2, 1998, Pages 237-254

  Hailey, David ^a   Sampietro Colom, Laura ^b   Marshall, Deborah ^a   Rico, Rosa ^c   Granados, Alicia ^b   Asua, José ^d  

^a ALBERTA ENVIRONMENT AND PARKS   (Canada)

^b Catalan Agy Hlth Technol Assess

^c Basque Off for Technol Assessment

^d Basque Off Hlth Technol Assess

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; BONE DENSITY; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FRACTURE; HORMONE SUBSTITUTION; MEASUREMENT; REVIEW; SCREENING; TREATMENT OUTCOME;

EID: 0031862370     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462300012228     Document Type: Review

References (19)

1. Agence Nationale pour le D́veloppement de l'Evaluation Médicale. Evaluation de l'osteodensitometrie. Paris: ANDEM 1991.
2. Cagnacci, A., Melis, G. B., Soldani, R., et al. Neuroendocrine and clinical effects of transdermal 17 beta-estradiol in postmenopausal women. Maturitas, 1991,13, 283-96.
3. Canadian Task Force on the Periodic Health Examination. The periodic health examination. Canadian Medical Association Journal, 1979, 121, 1193-254.
4. Catalan Agency for Health Technology Assessment. La calcitonina en el tractament de la osteoporosis idiopatica, Barcelona: CAHTA, 1994.
5. Cauley, J. A., Seeley, D. G., Ensrud, K., et al. Estrogen replacement therapy and fractures in older women: Study of osteoporotic Fractures Research Group. Annals of Internal Medicine, 1995, 122, 9-16.
6. Center for Health Care Technology. Bone densitometry: Patients with end stage disease. Rockville, MD: Agency for Health Care Policy and Research, 1996.
7. Christiansen, C., Christensen, M. S., & Transbol, I. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet, 1981, 1, 459-61.
8. Cicinelli, E., Galantino, P., Pepe, V., et al. Bone metabolism changes after transdermal estradiol dose reduction during estrogen replacement therapy: A 1-year prospective study. Maturitas, 1994, 19, 133-39.
9. Cochrane, A. L., & Holland, W. W. Validation of screening procedures. British Medical Bulletin, 1971, 27, 3-8.
10. Cooper, C., Kanis, J. A., & Compston, J. How to assess drug efficacy in osteoporosis. Lancet, 1995, 34, 743-44.
11. Cranney, A., Shea, B., Wells, G., et al. Calcitonin treatment of post-menopausal osteoporosis. In P. Brooks, M. Bosi-Ferraz, R. de Bie, et al. (eds.), Musculoskeletal module of the Cochrane Database of Systematic Reviews, Oxford: UK Cochrane Centre, 1996.
12. Cummings, S. R., Nevitt, M. C., Browner, W. S., et al. Risk factors for hip fracture in white women: Study of Osteoporotic Fractures Research Group. New England Journal of Medicine, 1995, 332, 767-73.
13. Davis, J. W., Ross, P. D., Johnson, N. E., et al. Estrogen and calcium supplement use among Japanese-American women: Effects upon bone loss when used singly and in combination. Bone, 1995, 17, 369-73.
14. Diagnostic and Therapeutic Technology Assessment (DATTA). Measurement of bone density with dual-energy x-ray absorptiometry (DEXA). Journal of the American Medical Association, 1992, 267, 290-94.
15. Draper, J., & Roland, M. Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis. British Medical Journal, 1990, 300, 786-88.
16. Ettinger, B., Genant, H. K., & Cann, C. E. Long-term estrogen replacement therapy prevents bone loss and fractures. Annals of Internal Medicine, 1985, 102, 319-24.
17. Felson, D. T., Zhang, Y., Hannan, M. T., et al. The effect of postmenopausal estrogen therapy on bone density in elderly women. New England Journal of Medicine, 1993, 329, 1141-46.
18. Field, C. S., Ory, S. J., Wahner, H. W., et al. Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: A two-year placebo controlled trial. American Journal of Obstetrics and Gynecology, 1993, 168, 114-21.
19. Fioretti, P., Gambacciani, M., Taponeco, F., et al. Effects of continuous and cyclic nasal calcitonin administration in ovariectomized women. Maturitas, 1992, 15, 225-32.